- Home
- SER vs ABVC Comparison
SER vs ABVC Comparison
Compare SER & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SER
- ABVC
- Stock Information
- Founded
- SER 2017
- ABVC 2015
- Country
- SER United States
- ABVC United States
- Employees
- SER N/A
- ABVC N/A
- Industry
- SER Biotechnology: Pharmaceutical Preparations
- ABVC Biotechnology: Pharmaceutical Preparations
- Sector
- SER Health Care
- ABVC Health Care
- Exchange
- SER Nasdaq
- ABVC Nasdaq
- Market Cap
- SER 56.5M
- ABVC 52.1M
- IPO Year
- SER 2018
- ABVC N/A
- Fundamental
- Price
- SER $5.40
- ABVC $3.01
- Analyst Decision
- SER Strong Buy
- ABVC
- Analyst Count
- SER 2
- ABVC 0
- Target Price
- SER $13.00
- ABVC N/A
- AVG Volume (30 Days)
- SER 23.9K
- ABVC 729.3K
- Earning Date
- SER 08-08-2025
- ABVC 08-13-2025
- Dividend Yield
- SER N/A
- ABVC N/A
- EPS Growth
- SER N/A
- ABVC N/A
- EPS
- SER N/A
- ABVC N/A
- Revenue
- SER $51,000.00
- ABVC $508,383.00
- Revenue This Year
- SER N/A
- ABVC $735.18
- Revenue Next Year
- SER N/A
- ABVC N/A
- P/E Ratio
- SER N/A
- ABVC N/A
- Revenue Growth
- SER N/A
- ABVC 1904.43
- 52 Week Low
- SER $3.81
- ABVC $0.40
- 52 Week High
- SER $11.57
- ABVC $5.48
- Technical
- Relative Strength Index (RSI)
- SER 45.42
- ABVC 50.14
- Support Level
- SER $5.11
- ABVC $2.91
- Resistance Level
- SER $5.67
- ABVC $3.39
- Average True Range (ATR)
- SER 0.38
- ABVC 0.58
- MACD
- SER -0.01
- ABVC -0.14
- Stochastic Oscillator
- SER 38.52
- ABVC 3.89
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.